Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NeoGenomics Laboratories, Inc. (NEO) · oqro.io/stocks/NEO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Since the trade +169.9% · S&P 500 +9.0% · to Nov 20
The CEO of NeoGenomics Laboratories paid $100K out of pocket for NeoGenomics Laboratories shares. 1 other person at NeoGenomics Laboratories bought some too, in the same month. Shares held went up 89% with this purchase.
Since the trade +169.9% · S&P 500 +9.0% · to Nov 20
The CFO of NeoGenomics Laboratories paid $112K out of pocket for NeoGenomics Laboratories shares. 1 other person at NeoGenomics Laboratories bought some too, in the same month. Shares held went up 12% with this purchase.
Since the trade +97.6% · S&P 500 +16.7% · to Nov 20
A NeoGenomics Laboratories director paid $38K out of pocket for NeoGenomics Laboratories shares. 6 other people at NeoGenomics Laboratories bought some too, in the same month.
Since the trade +74.2% · S&P 500 +18.3% · to Nov 20
NeoGenomics Laboratories's Pres & Chief Operating Officer paid $49K out of pocket for NeoGenomics Laboratories shares. 6 other people at NeoGenomics Laboratories bought some too, in the same month. Shares held went up 6% with this purchase.
Since the trade +85.3% · S&P 500 +22.9% · to Nov 20
A NeoGenomics Laboratories director paid $31K out of pocket for NeoGenomics Laboratories shares. 6 other people at NeoGenomics Laboratories bought some too, in the same month. Shares held went up 11% with this purchase.
Since the trade +84.1% · S&P 500 +22.2% · to Nov 20
A NeoGenomics Laboratories director paid $57K out of pocket for NeoGenomics Laboratories shares. 6 other people at NeoGenomics Laboratories bought some too, in the same month.
Since the trade +92.7% · S&P 500 +23.4% · to Nov 20
The CEO of NeoGenomics Laboratories paid $149K out of pocket for NeoGenomics Laboratories shares. 6 other people at NeoGenomics Laboratories bought some too, in the same month.
Since the trade +89.0% · S&P 500 +22.4% · to Nov 20
A NeoGenomics Laboratories director paid $35K out of pocket for NeoGenomics Laboratories shares. 6 other people at NeoGenomics Laboratories bought some too, in the same month. Shares held went up 40% with this purchase.
Since the trade +89.0% · S&P 500 +22.4% · to Nov 20
A NeoGenomics Laboratories director paid $76K out of pocket for NeoGenomics Laboratories shares. 6 other people at NeoGenomics Laboratories bought some too, in the same month.
0 open-market purchases and 0 open-market sales by insiders of NEO between Mar 29, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 28, 2026. The data provider lists the next release for Feb 15, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies